Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: Insitro Lands Three-year Deal With Gilead To Find New Nash Drugs
Venture Capital

Xconomy: Insitro Lands Three-year Deal With Gilead To Find New Nash Drugs

by xconomy.com posted 4months ago 15 views
Drug discovery startup Insitro burst onto the scene last year with ambitions of using machine learning techniques to find new therapies. Now the company has its first pharmaceutical partner. Gilead Sciences will work with Insitro to find medicines to treat a liver disease, nonalcoholic steatohepatitis (NASH), that is fast becoming a global epidemic fueled by […]

In this article